Literature DB >> 19733664

Involvement of CHOP, an ER-stress apoptotic mediator, in both human sporadic ALS and ALS model mice.

Yasushi Ito1, Mitsunori Yamada, Hirotaka Tanaka, Kazunari Aida, Kazuhiro Tsuruma, Masamitsu Shimazawa, Isao Hozumi, Takashi Inuzuka, Hitoshi Takahashi, Hideaki Hara.   

Abstract

Endoplasmic reticulum (ER) stress-induced neuronal death may play a critical role in the pathogenesis of amyotrophic lateral sclerosis (ALS). However, whether CCAAT/enhancer binding protein (C/EBP) homologous protein (CHOP), an ER-stress apoptotic mediator, is involved in the pathogenesis of ALS is controversial. Here we demonstrate the expression levels and localization of CHOP in spinal cords of both sporadic ALS patients and ALS transgenic mice by immunohistochemistry. In the spinal cords of sporadic ALS patients, CHOP was markedly up-regulated but typically expressed at low levels in those of the control. Likewise, CHOP expression increased at 14 (symptomatic stage) and 18 to 20 weeks (end stage) in ALS transgenic mice spinal cords. Furthermore, localizations of CHOP were merged in motor neurons and glial cells, such as oligodendrocytes, astrocytes, and microglia. These results indicate that the up-regulation of CHOP in motor neurons and glial cells may play pivotal roles in the pathogenesis of ALS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19733664     DOI: 10.1016/j.nbd.2009.08.013

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  45 in total

Review 1.  ER stress and the unfolded protein response in neurodegeneration.

Authors:  Claudio Hetz; Smita Saxena
Journal:  Nat Rev Neurol       Date:  2017-07-21       Impact factor: 42.937

2.  The UPR-PERK pathway is not a promising therapeutic target for mutant SOD1-induced ALS.

Authors:  Yulia Dzhashiashvili; Chase P Monckton; Harini S Shah; Rejani B Kunjamma; Brian Popko
Journal:  Neurobiol Dis       Date:  2019-03-26       Impact factor: 5.996

Review 3.  Disturbance of endoplasmic reticulum proteostasis in neurodegenerative diseases.

Authors:  Claudio Hetz; Bertrand Mollereau
Journal:  Nat Rev Neurosci       Date:  2014-03-12       Impact factor: 34.870

4.  PERK-dependent activation of JAK1 and STAT3 contributes to endoplasmic reticulum stress-induced inflammation.

Authors:  Gordon P Meares; Yudong Liu; Rajani Rajbhandari; Hongwei Qin; Susan E Nozell; James A Mobley; John A Corbett; Etty N Benveniste
Journal:  Mol Cell Biol       Date:  2014-08-11       Impact factor: 4.272

5.  Disruption of Endoplasmic Reticulum Proteostasis in Age-Related Nervous System Disorders.

Authors:  Danilo B Medinas; Younis Hazari; Claudio Hetz
Journal:  Prog Mol Subcell Biol       Date:  2021

Review 6.  The role of endoplasmic reticulum stress in astrocytes.

Authors:  Savannah G Sims; Rylee N Cisney; Marissa M Lipscomb; Gordon P Meares
Journal:  Glia       Date:  2021-08-31       Impact factor: 8.073

7.  Fasudil, a rho kinase inhibitor, limits motor neuron loss in experimental models of amyotrophic lateral sclerosis.

Authors:  M Takata; H Tanaka; M Kimura; Y Nagahara; K Tanaka; K Kawasaki; M Seto; K Tsuruma; M Shimazawa; H Hara
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

8.  C/EBP homologous binding protein (CHOP) underlies neural injury in sleep apnea model.

Authors:  Yu-Ting Chou; Guanxia Zhan; Yan Zhu; Polina Fenik; Lori Panossian; Yanpeng Li; Jing Zhang; Sigrid Veasey
Journal:  Sleep       Date:  2013-04-01       Impact factor: 5.849

9.  Multi-OMICS study of a CHCHD10 variant causing ALS demonstrates metabolic rewiring and activation of endoplasmic reticulum and mitochondrial unfolded protein responses.

Authors:  Isabella R Straub; Woranontee Weraarpachai; Eric A Shoubridge
Journal:  Hum Mol Genet       Date:  2021-05-17       Impact factor: 6.150

Review 10.  Protein misdirection inside and outside motor neurons in Amyotrophic Lateral Sclerosis (ALS): a possible clue for therapeutic strategies.

Authors:  Akemi Ido; Hidenao Fukuyama; Makoto Urushitani
Journal:  Int J Mol Sci       Date:  2011-10-19       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.